Suppr超能文献

Miq(一种植物)乙醇叶提取物对Sprague-Dawley大鼠的抗糖尿病特性及毒理学评估

Antidiabetic Properties and Toxicological Assessment of Miq: Ethanolic Leaves Extract in Sprague-Dawley Rats.

作者信息

Pratiwi Raysa Y, Elya Berna, Setiawan Heri, Forestrania Roshamur C, Dewi Rizna T

机构信息

Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia.

Research Center for Chemistry, Indonesian Institute of Sciences, Serpong, Indonesia.

出版信息

Adv Pharmacol Pharm Sci. 2022 May 24;2022:2584698. doi: 10.1155/2022/2584698. eCollection 2022.

Abstract

is a genus of plants, and its several species are known to have antidiabetic properties. Leaves of Kayu Tuah ( Miq) have been proven to have the best -glucosidase inhibition ability compared to other species in the genus, as evidenced by the in vitro -glucosidase inhibition test. However, no scientific studies have reported its antidiabetic properties and toxicity in vivo. Therefore, this research managed to verify the antidiabetic features and safety of ethanolic extract of leaves (EEAC) in Sprague-Dawley rats. Male rats (170-280 g) were induced diabetic with streptozotocin (35 mg/kg BW) and fed a high-fat diet comprising 24% fat, whereas control group rats were given a standard diet. Rats were treated with EEAC at 200 and 400 mg/kg BW doses for 28-days and 60 mg/kg BW acarbose for the control group. Determination of antidiabetic properties was done by analyzing lipid profiles as well as fasting blood glucose. After confirming the antidiabetic properties of EEAC, the toxicological assessment was determined using the fixed-dose method. General behavior changes, appearance, signs of toxicity, mortality, and body weight of animals were marked down during the observation period. When the treatment period ended, hematological, biochemical, and histological examinations of liver, kidneys, and heart sections were performed. The results confirmed that EEAC reduced fasting blood glucose levels and stepped forward lipid profiles of rats. Also, all animals survived, and no obvious destructive outcomes were noticeable during the study. As EEAC has promising results toward hyperglycemia and hyperlipidemia and has been proven safe through toxicity tests, it can be concluded that EEAC has good potential to be further developed into antidiabetic drugs.

摘要

是一个植物属,已知其几个物种具有抗糖尿病特性。与该属中的其他物种相比,Kayu Tuah(Miq)的叶子已被证明具有最佳的α-葡萄糖苷酶抑制能力,体外α-葡萄糖苷酶抑制试验证明了这一点。然而,尚无科学研究报道其体内抗糖尿病特性和毒性。因此,本研究成功验证了Kayu Tuah叶子乙醇提取物(EEAC)对Sprague-Dawley大鼠的抗糖尿病特性和安全性。雄性大鼠(170-280克)用链脲佐菌素(35毫克/千克体重)诱导糖尿病,并喂食含24%脂肪的高脂肪饮食,而对照组大鼠给予标准饮食。大鼠分别以200和400毫克/千克体重的剂量用EEAC治疗28天,对照组用60毫克/千克体重的阿卡波糖治疗。通过分析脂质谱以及空腹血糖来确定抗糖尿病特性。在确认EEAC的抗糖尿病特性后,使用固定剂量法进行毒理学评估。在观察期内记录动物的一般行为变化、外观、毒性迹象、死亡率和体重。治疗期结束后,对肝脏、肾脏和心脏切片进行血液学、生化和组织学检查。结果证实,EEAC降低了大鼠的空腹血糖水平,并改善了脂质谱。此外,所有动物均存活,在研究期间未观察到明显的不良后果。由于EEAC对高血糖和高血脂有良好的效果,并且通过毒性试验已证明是安全的,可以得出结论,EEAC具有进一步开发成抗糖尿病药物的良好潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/9155931/3f2a0d514d64/APS2022-2584698.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验